On Nursing in Radiology Now, In the Midst of This COVID-19 Pandemic
Nursing in radiology, the profession that I love, has always been a complex job. Typically, a day's work for a radiology nurse can include consoling a crying child having an...
A Deep Learning Model Predicts Total Knee Replacement (TKR) from MRI
Knee osteoarthritis (OA) is a common musculoskeletal disorder in the U.S. with an incident rate ranging from 14 to 30 million. Overall annual arthritis-related medical expenditures are nearly $140 million,...
Pilot Tolerability Studies of Hydroxychloroquine and Colchicine in Alzheimer Disease
Summary:
Anti-inflammatory drugs may be useful in the treatment of Alzheimer disease (AD). In preparation for therapeutic trials, we conducted pilot feasibility studies of hydroxychloroquine alone and in combination with colchicine in subjects with AD....
Early-Life Risk Factors for Alzheimer Disease
Abstract:
Research findings obtained over the past 20 years suggest that Alzheimer disease (AD) may have its origins in early life. In this review, we consider the evidence for early-life risk factors for this illness....
Celebrating Our Nurses | UCSF Radiology
Wednesday, May 6, is National Nurses Day and marks the beginning of National Nurses Week.
Reflecting on the healing and deeply personal care that the radiology nursing teams provide every day...
SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer’s...
1.Shaw, L. M. et al. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann. Neurol. 65, 403–413, https://doi.org/10.1002/ana.21610 (2009).2.McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations...
Incidence of Dementia in England and Wales: The MRC Cognitive Function and Ageing Study
No abstract available
Read more...
Andreas Rauschecker, MD, PhD is Presented with the 2019-20 Long-Term Mentor Award
The UC San Francisco Department of Radiology and Biomedical Imaging would like to congratulate and recognize Andreas Rauschecker, MD, PhD, clinical fellow, on receiving the 2019-2020 UCSF Inquiry Curriculum Long-Term...
Memantine Treatment of Cognitive Symptoms in Mild to Moderate Alzheimer Disease: Secondary Analyses From...
Memantine, an N-methyl-D-aspartate receptor antagonist, is approved in the United States and Europe for the treatment of moderate to severe Alzheimer disease (AD) and has also been investigated in patients with mild to moderate...